Document Detail


In vitro chemosensitivity and radiosensitivity of an adriamycin-resistant subline of human small cell lung cancer cells.
MedLine Citation:
PMID:  3012966     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Using a cell line (SBC-3/ADM) of human small cell lung cancer, which is 30-fold more resistant to adriamycin than the parent cell line (SBC-3), the activity of a variety of anticancer agents was analyzed by soft agar clonogenic assay to search for a means of circumventing drug resistance. The SBC-3/ADM cells were markedly resistant to some anthracycline antibiotics in comparison with the SBC-3 cells: 28-fold for daunomycin, 26-fold for 4'-epiadriamycin, 18-fold for THP-adriamycin, and 8.4-fold for aclarubicin. However, the cells were as sensitive to mitoxantrone, one of the anthraquinone derivatives, as the parent cells. The cells were resistant to structurally or pharmacodynamically unrelated compounds such as vincristine, mitomycin C, and an active form of ifosfamide, whereas they were susceptible to cisplatin to some extent. The in vitro radiosensitivity of both cell lines was also evaluated, and they were found to be equally sensitive to X-ray. These results suggest that mitoxantrone and cisplatin may exert sufficient activity for small cell lung cancer which has acquired resistance to adriamycin, and that consolidative chest irradiation may be clinically useful after combination chemotherapy including adriamycin.
Authors:
H Miyamoto
Related Documents :
2185316 - C3-cleaving membrane proteinase. a new complement regulatory protein of human melanoma ...
22108526 - Changes in cell wall biomechanical properties in the xyloglucan-deficient xxt1/xxt2 mut...
10844656 - Identification of genes affecting selenite toxicity and resistance in saccharomyces cer...
11847216 - 4e-binding proteins, the suppressors of eukaryotic initiation factor 4e, are down-regul...
1901716 - Neuronal determination without cell division in xenopus embryos.
2157986 - Mitosis-specific phosphorylation causes 83k non-muscle caldesmon to dissociate from mic...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Acta medica Okayama     Volume:  40     ISSN:  0386-300X     ISO Abbreviation:  Acta Med. Okayama     Publication Date:  1986 Apr 
Date Detail:
Created Date:  1986-06-27     Completed Date:  1986-06-27     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0417611     Medline TA:  Acta Med Okayama     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  75-81     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anthraquinones / pharmacology
Antineoplastic Agents / pharmacology
Carcinoma, Small Cell / drug therapy*,  pathology,  radiotherapy
Cell Line
Cell Survival / drug effects,  radiation effects
Cisplatin / pharmacology
Dose-Response Relationship, Drug
Doxorubicin / pharmacology*
Drug Resistance
Humans
Lung Neoplasms / drug therapy*,  pathology,  radiotherapy
Mitoxantrone
Tumor Stem Cell Assay
Chemical
Reg. No./Substance:
0/Anthraquinones; 0/Antineoplastic Agents; 15663-27-1/Cisplatin; 23214-92-8/Doxorubicin; 65271-80-9/Mitoxantrone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Establishment and characterization of an adriamycin-resistant subline of human small cell lung cance...
Next Document:  Type IV collagen-degrading enzyme activity in hepatocellular carcinoma.